BRCA mutation carriers’ perception about benefits and risks associated with combined hormonal contraceptives use

References

• Skouby SO. Contraceptive use and behavior in the 21st century: a comprehensive study across five european countries. Eur J Contracept Reprod Health Care. 2004;9(2):57–68.
   PubMed Web of Science ®Google Scholar
• Kavanaugh ML, Jerman J. Contraceptive method use in the United States: trends and characteristics between 2008 and 2014. Contraception. 2018;97(1):14–21.
   PubMed Web of Science ®Google Scholar
• Weitzman A, Barber J, Kusunoki Y. Sexual concurrency and contraceptive use among young adult women. Demography. 2019;56(2):549–572.
   PubMed Web of Science ®Google Scholar
• Hooper DJ. Attitudes, awareness, compliance and preferences among hormonal contraception users: a global, cross-sectional, self-administered, online survey. Clin Drug Investig. 2010;30(11):749–763.
   PubMed Web of Science ®Google Scholar
• Lopez-del Burgo C, Mikolajczyk RT, Osorio A, et al. Knowledge and beliefs about mechanism of action of birth control methods among European women. Contraception. 2012;85(1):69–77.
   PubMed Web of Science ®Google Scholar
• Machado RB, de Melo NR, Prota FE, et al. Women’ s knowledge of health effects of oral contraceptives in five Brazilian cities. Contraception. 2012;86(6):698–703.
   PubMedGoogle Scholar
• Philipson S, Wakefi eld CE, Kasparian NA. Women’ s knowledge, beliefs, and information needs in relation to the risks and benefits associated with use of the oral contraceptive pill. J Womens Health. 2011;20(4):635–642.
   Google Scholar
• Sokkary N, Mansouri R, Yoost J, et al. A multicenter survey of contraceptive knowledge among adolescents in North America. J Pediatr Adolesc Gynecol. 2013;26(5):274–276.
   PubMedGoogle Scholar
• Nappi RE, Pellegrinelli A, Campolo F, et al. Effects of combined hormonal contraception on health and wellbeing: women’s knowledge in Northern Italy. Eur J Contracept Reprod Health Care. 2015;20(1):36–46.
   PubMed Web of Science ®Google Scholar
• Grandi G, Sammarini M, Del Savio MC, et al. Combined hormonal contraceptives in BRCA gene mutation carriers: why not? Eur J Contracept Reprod Health Care. 2019;24(6):417–419.
   PubMed Web of Science ®Google Scholar
• Brohet RM, Goldgar DE, Easton DF, et al. Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS collaborating group. J Clin Oncol. 2007;25(25):3831–3836.
   PubMedGoogle Scholar
• Narod SA, Risch H, Moslehi R, et al. Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary ovarian cancer clinical study group. N Engl J Med. 1998;339(7):424–428.
   PubMed Web of Science ®Google Scholar
• McGuire V, Felberg A, Mills M, et al. Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations. Am J Epidemiol. 2004;160(7):613–618.
   PubMedGoogle Scholar
• Havrilesky LJ, Moorman PG, Lowery WJ, et al. Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and Meta-analysis. Obstet Gynecol. 2013;122(1):139–147.
   PubMed Web of Science ®Google Scholar
• Schrijver LH, Antoniou AC, Olsson H, et al. Epidemiological study of familial breast cancer, gene etude prospective sein ovaire sein, hereditary breast and ovarian cancer research group Netherlands, and international BRCA1/2 carrier cohort study. Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study. Am J Obstet Gynecol. 2021;225(1):51.e1–51.e17.
   PubMed Web of Science ®Google Scholar
• Zolfaroli I, Tarin JJ, Cano A. Hormonal contraceptives and breast cancer: clinical data. Eur J Obstet Gynecol Reprod Biol. 2018;230:212–216.
   PubMedGoogle Scholar
• Moorman PG, Havrilesky LJ, Gierisch JM, et al. Oral contraceptives and risk of ovarian cancer and breast cancer among highrisk women: a systematic review and meta-analysis. J Clin Oncol. 2013;31(33):4188–4198.
   PubMed Web of Science ®Google Scholar
• Grandi G, Toss A, Cagnacci A, et al. Combined hormonal contraceptive use and risk of breast cancer in a population of women with a family history. Clin Breast Cancer. 2018;18(1):e15–e24.
   PubMed Web of Science ®Google Scholar
• Jernstrom H, Loman N, Johannsson OT, et al. Impact of teenage oral contraceptive use in a population-based series of early onset breast cancer cases who have undergone BRCA mutation testing. Eur J Cancer. 2005;41(15):2312–2320.
   PubMedGoogle Scholar
• Toss A, Grandi G, Cagnacci A, et al. The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation. Oncotarget. 2017;8(6):9144–9154.
   PubMedGoogle Scholar
• Bui KT, Wakefield CE, Kasparian NA, et al. Oral contraceptive use in women at increased risk of breast/ovarian cancer: knowledge and attitudes. Psychooncology. 2013;22(1):228–232.
   PubMedGoogle Scholar
• Grandi G, Boggio Sola V, Cortesi L, et al. BRCA mutation carriers’ perceptions on postmenopausal hormone therapy: an Italian study. Psychooncology. 2021;30(10):1711–1719.
   PubMed Web of Science ®Google Scholar
• Grandi G, Del Savio MC, Boggio Sola V, et al. Attitudes of women towards products containing hormones (hormonal contraceptives or hormone therapy): what changes from pre to postmenopause? Ann Med. 2021;53(1):908–915.
   PubMed Web of Science ®Google Scholar
• Lidegaard Ø, Nielsen LH, Skovlund CW, et al. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001–09. BMJ. 2011;343:d6423.
   PubMed Web of Science ®Google Scholar
• Mulatero P, Morra di Cella S, Veglio F. Hypertension, genotype and oral contraceptives. Pharmacogenomics. 2002;3(1):57–63.
   PubMedGoogle Scholar
• Stuart GS, Castaño PM. Sexually transmitted infections and contraceptives: selective issues. Obstet Gynecol Clin North Am. 2003;30(4):795–808.
   PubMedGoogle Scholar
• Teal S, Edelman A. Contraception selection, effectiveness, and adverse effects: a review. JAMA. 2021;326(24):2507–2518.
   PubMedGoogle Scholar
• Callahan R, Yacobson I, Halpern V, et al. Ectopic pregnancy with use of progestin-only injectables and contraceptive implants: a systematic review. Contraception. 2015;92(6):514–522.
   PubMedGoogle Scholar
• Whitaker L, Critchley HO. Abnormal uterine bleeding. Best Pract Res Clin Obstet Gynaecol. 2016;34:54–65.
   PubMed Web of Science ®Google Scholar
• Robakis T, Williams KE, Nutkiewicz L, et al. Hormonal contraceptives and mood: review of the literature and implications for future research. Curr Psychiatry Rep. 2019;21(7):57.
   PubMed Web of Science ®Google Scholar
• MacGregor EA. Contraception and headache. Headache. 2013;53(2):247–276.
   PubMed Web of Science ®Google Scholar
• Gallo MF, Lopez LM, Grimes DA, et al. Combination contraceptives: effects on weight. Cochrane Database Syst Rev. 2011;2011(9):CD003987.
   Google Scholar
• Burrows LJ, Basha M, Goldstein AT. The effects of hormonal contraceptives on female sexuality: a review. J Sex Med. 2012;9(9):2213–2223.
   PubMed Web of Science ®Google Scholar
• Asthana S, Busa V, Labani S. Oral contraceptives use and risk of cervical cancer-A systematic review & Meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2020;247:163–175.
   PubMedGoogle Scholar
• Iversen L, Sivasubramaniam S, Lee AJ, et al. Lifetime cancer risk and combined oral contraceptives: the royal college of general practitioners’ oral contraception study. Am J Obstet Gynecol. 2017;216(6):580.e1–580.e9.
   PubMed Web of Science ®Google Scholar
• Mueck AO, Seeger H, Rabe T. Hormonal contraception and risk of endometrial cancer: a systematic review. Endocr Relat Cancer. 2010;17(4):R263–71.
   PubMed Web of Science ®Google Scholar
• Bosetti C, Bravi F, Negri E, et al. Oral contraceptives and colorectal cancer risk: a systematic review and Meta-analysis. Hum Reprod Update. 2009;15(5):489–498.
   PubMed Web of Science ®Google Scholar
• Sangi-Haghpeykar H, Ali N, Posner S, et al. Disparities in contraceptive knowledge, attitude and use between hispanic and nonHispanic whites. Contraception. 2006;74(2):125–132.
   PubMed Web of Science ®Google Scholar
• Kuchenbaecker KB, Hopper JL, Barnes DR, et al. BRCA1 and BRCA2 cohort consortium. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017;317(23):2402–2416.
   PubMed Web of Science ®Google Scholar
• Mørch LS, Skovlund CW, Hannaford PC, et al. Contemporary hormonal contraception and the risk of breast cancer. N Engl J Med. 2017;377(23):2228–2239.
   PubMed Web of Science ®Google Scholar
• Envall N, Emtell Iwarsson K, Bizjak I, et al. Evaluation of satisfaction with a model of structured contraceptive counseling: results from the LOWE trial. Acta Obstet Gynecol Scand. 2021;100(11):2044–2052.
   PubMed Web of Science ®Google Scholar
• Kopp Kallner H, Thunell L, Brynhildsen J, et al. Use of contraception and attitudes towards contraceptive use in Swedish women–a nationwide survey. PLoS One. 2015;10(5):e0125990.
   PubMed Web of Science ®Google Scholar
• Lamvu G, Steiner MJ, Condon S, et al. Consistency between most important reasons for using contraception and current method used: the influence of health care providers. Contraception. 2006;73(4):399–403.
   PubMed Web of Science ®Google Scholar